Webinar: Inflammatory Bowel Disease Drug Market Trends

Inflammatory Bowel Disease Drug Market Trends

Are you looking to gain in-depth knowledge of the latest advancements and market trends in Inflammatory Bowel Disease (IBD)? Cut through the noise and discover how innovative modalities like JAK inhibitors, TNF alpha inhibitors, and S1P modulators are revolutionizing patient care and driving market growth. Learn about the latest trends, research milestones, and future opportunities in this thriving field.

Inflammatory Bowel Disease Drug Market Webinar

This webinar provided a robust analysis of important drug modalities including JAK inhibitors, TNF alphas, and S1P modulators, a review of recent drug approvals, discontinuations, and trial-reported adverse events, and market insights surrounding the latest trends, factors driving growth and leading players in the IBD sectors. Watch the recording now.

View Webinar

Our Experts

Rachel Hourigan

House Speaker

Research Analyst

Beacon

Joseph Moss

House Speaker

Senior Market Analyst

Hanson Wade Intelligence

Farrah Vogel-Javeri

Moderator

Scientific Liaison Analyst

Beacon

You May Also Be Interested In…

Immune Tolerance Landscape Review

Access Review

T Cell Engagers: Revolutionizing Autoimmune Disease Treatment

Access Infographic

EULAR 2024: Immune Tolerance Post-Conference Report

Access Report

View All

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more